electroCore (ECOR) News
NASDAQ: ECORHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ECOR news summary
We found 5 recent headlines mentioning electroCore (ECOR): 0 in the past week and 5 in the past 30 days, most often from Nasdaq, GlobeNewswire. ECOR is making an outsized move today, down 8.87% at $4.42, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Randomized Study of Non-Invasive Autonomic Neuromodulation for Long COVID Published Online in Neuromodulation", was published by GlobeNewswire on Nov 12, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest electroCore headlines
- Randomized Study of Non-Invasive Autonomic Neuromodulation for Long COVID Published Online in NeuromodulationRandomized, open-label, hypothesis-generating study (541 participants enrolled; 250 met final analysis criteria) evaluated two proprietary non-invasive neuromodulation technologies, electroCore’s…GlobeNewswire
- electroCore (ECOR) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- electroCore Announces Third Quarter 2026 Financial ResultsThird quarter 2026 net sales of $9.7 million, an increase of 12% over $8.7 millionGlobeNewswire
- Neurocrine Biosciences (NBIX) Q3 Earnings and Revenues Top EstimatesNeurocrine (NBIX) delivered earnings and revenue surprises of +29.53% and +8.12%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqNBIX, ECOR
- ElectroCore Files FDA Submission For Quell In Persistent Chemotherapy-Related Neuropathy; Stock Up(RTTNews) - electroCore, Inc. (ECOR) announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) seeking clearance for its Quell wearable…NasdaqECOR, BRK.B